MedTrace Logo

Smartphone-Based Neurobehavioral Assessments as a Diagnostic Aid in Autism

NCT06497218 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2024-07-12

No results posted yet for this study

Summary

Retrospective case-control study to assess the diagnostic accuracy in autism spectrum disorder (ASD) of a new smartphone-based platform designed to conduct neurometric evaluations by measuring facial and behavioural reflexes.

Conditions

Interventions

DIAGNOSTIC_TEST

Blinklab diagnostic device

Blinklab is a non-invasive diagnostic device for Autism Spectrum Disorder

Sponsors & Collaborators

  • Mohammed VI National Center for the Disabled, Salé, Morocco

    collaborator UNKNOWN

  • Blinklab Limited

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2024-10-16
Completion
2025-01-15

Countries

  • Morocco

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06497218 on ClinicalTrials.gov